Track topics on Twitter Track topics that are important to you
Complete report $34,500.nbsp;nbsp;DataPack test volumes, sales forecasts, supplier shares $21,100.
This comprehensive sevencountry report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global coagulation testing market during the next five years.
The report explores business and technological trends in the US, Europe France, Germany, Italy, Spain, UK and Japan; provides estimates of the test volume, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
The growing costcontainment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.
New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Activated Clotting Time ACT 1, Activated Protein C Resistance, Activated PTT APTT, Alpha 2Antiplasmin, Antithrombin III, Bleeding Time, DDimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X Stuart Factor, Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/PreKallikrein Factor Activation, Heparin/AntiFactor Xa, HeparinInduced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time PT, Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Extensive strategic profiles of major suppliers and emerging market entrants.
Market Segmentation Analysis
Comprehensive market segmentation analysis, including:
nbsp;nbsp;nbsp;nbsp; Commercial/Private Laboratories
nbsp;nbsp;nbsp;nbsp; Physician Offices
nbsp;nbsp;nbsp;nbsp; Ambulatory Care Centers
Test volume forecasts nbsp;for over 40 major procedures, by country and market segment.
Current and Emerging Products
Review of established and emerging procedures.
Comparison of automated and semiautomated analyzers from Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Analysis of current and emerging technologies and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Worldwide Market Overview
Estimates of facilities performing coagulation tests by country.
Test volume and sales projections by country.
Product development and business expansion opportunities with significant market appeal.
ldquo;Idealrdquo; product models with tentative prices and operating characteristics.
Alternative market penetration strategies for instrument and reagent suppliers.
Potential market entry barriers and risks.
Contains 650 pages and 150 tables
Original Article: Hemostasis Analyzers and Reagents Market 2021: Supplier Shares and Sales Forecasts by CountryUS, Europe, JapanCompetitive Intelligence, Technology and Instrumentation Review, Opportunities for Suppliers [Report Updated: 25082017] Prices from USD $34500NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...
Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...